Seeking additional funds

The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate wound healing progression using a new hyperspectral imaging technology.

The purpose of this clinical study is to define patient eligibility for hyperbaric oxygen therapy (HBOT) and to evaluate wound healing progression during HBOT using a new hyperspectral imaging technology (OxyVu).

Inclusion criteria:

• 18 - 85 years of age
• Patients with wounds that meet the criteria for hyperbaric oxygen therapy (e.g. problem wound, diabetic foot ulcer, necrotizing soft tissue infections)
• Compromised Flap or Grafts.

Exclusion criteria:

• Patients with poor cardiac output (EF < 20%)
• Patients with severe obstructive pulmonary disease who don't qualify for HBOT
• Patients with untreated asthma who don't qualify for HBOT
• Patients utilizing supplemental oxygen and those on ventilators
• Patients on life support medications (pressors)

18 to 85 years of age, males and females, and with and without diabetes and untreatable peripheral vascular disease.